From Grassroots to Policy

From Grassroots to Policy

Pregnancy refers to the period from conception until birth. It can be verified using various pregnancy tests and presumptive signs and symptoms (Aziz et al., 2018). Women are usually advised to start antenatal care in the first trimester (Aziz et al., 2018). Antenatal care facilitates early diagnosis and management of pregnancy-related complications such as hypertension, constipation, emesis, gestational diabetes, anxiety, and depression (Aziz et al., 2018).

Health practices and beliefs such as clinical research, obstetric risks, and psychosocial difficulties increase the vulnerability of pregnant women (Heyrana et al., 2018; Mei et al., 2021). In clinical research, pregnant women must make decisions on behalf of the fetus. Subsequently, this predisposes both the pregnant woman and the fetus to harm (Heyrana et al., 2018). Furthermore, little information exists on the safety and efficacy of certain medications during pregnancy (Heyrana et al., 2018). Therefore, when they participate in clinical research, their risk of exposure is higher than the general population (Heyrana et al., 2018). Common obstetrics complications such as preeclampsia and gestational diabetes increase the morbidity rates of pregnant women (Aziz et al., 2018). As a result, this can lead to miscarriages and maternal deaths. Pregnant women are at increased risk of psychological difficulties such as depression and anxiety than the general population (Mei et al., 2021). Therefore, they should receive special attention to promote their mental well-being.

With an advanced nursing role, I can advocate for pregnant women by actively participating in policy formulation. This can be accomplished by working in concert with nursing associations such as the Association of Women’s Health, Obstetrics, and Neonatal Nursing (AWHONN, n.d.). Policies that advocate for affordable maternal-child health care services should be presented to Congress via a collaboration between the nursing associations and Congresspersons. Furthermore, the ethical review boards, data safety monitoring committees, and other regulatory agencies should enforce good clinical practices and detailed safety monitoring plans for clinical trials involving pregnant women. Ultimately, this will increase the safety of participants in the clinical trials.

Get in touch with us at eminencepapers.com. We offer assignment help with high professionalism.

References

AWHONN. (n.d.). Association of Women’s Health, Obstetric and Neonatal Nurses. https://www.awhonn.org/

Aziz, A. S., Ahmed, D. A., & Bano, A. G. (2018). Factors Affecting the Utilization of Antenatal Care Among Pregnant Women: A Literature Review. Journal of Pregnancy and Neonatal Medicine, 02(02). https://doi.org/10.35841/neonatal-medicine.2.2.41-45

Heyrana, K., Byers, H. M., & Stratton, P. (2018). Increasing the Participation of Pregnant Women in Clinical Trials. JAMA – Journal of the American Medical Association, 320(20), 2077–2078. https://doi.org/10.1001/jama.2018.17716

Mei, H., Li, N., Li, J., Zhang, D., Cao, Z., Zhou, Y., Cao, J., & Zhou, A. (2021). Depression, Anxiety, and Stress Symptoms in Pregnant Women Before and During the COVID-19 Pandemic. Journal of Psychosomatic Research, 149(9), 965–970. https://doi.org/10.1016/j.jpsychores.2021.110586

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

---

Discussion Prompt

Select and describe the key characteristics of one vulnerable population from your practice or locale and discuss why this population is considered vulnerable.

(I WORK IN THE MATERNAL DEPARTMENT) Include one or two health practices and beliefs of the chosen population that increase the vulnerability of the population. Describe how you, in an advanced nursing role, could be an advocate for this vulnerable population at the local, state or national level.
I WORK IN THE MATERNAL CHILD DEPARTMENT